UK hospital AI-enhanced cancer treatment is better for patients
AI enables patient emotions to be analyzed improving hospital experience. MELBOURNE, Australia, Oct. 16, 2023 – A new way to capture patient emotions is being pioneered by Healthscope to improve…
Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins. New technology uses AI with electron microscope images to reduce the development time…
Researchers use AI to measure facial reactions to emotions to gauge risk of depression
New AI tool beats standard approaches for detecting heart attacks
Atlas of human brain blood vessels highlights changes in Alzheimer’s disease
Machine learning uncovers the best drug combos to prevent COVID recurrence
Scientists develop AI tool to predict Parkinson's disease onset
Study Finds ChatGPT Outperforms Physicians in High-Quality, Empathetic Answers to Patient Questions. While AI won’t replace your doctor, the JAMA Internal Medicine paper suggests physicians working together with technologies like…
Deep learning AI model can identify at-risk infants for childhood blindness. AI breakthrough in detecting the leading cause of childhood blindness.
ChatGPT scores nearly 50% on board certification practice ophthalmology test
MIT researchers built DiffDock machine-learning model to find new drugs faster
Scientists develop powerful AI algorithm SPHINKS to gain new insights into deadly glioblastoma
Wearable tech, AI and clinical teams join to change the face of trial monitoring
Seoul National University plan to use Zero WiredTM to develop AI-based seizure detection medical device
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022.
GFlow Neural Networks to help discover new drug molecules and generate candidates
Government of Canada invests over $5.6 million to help early-stage genomics companies bring new products to market
FedDev Ontario investment to support over 30 companies, create and maintain 160 jobs, and develop eight new products, services or processes, and over 32 new patents.
Researchers from NYU Langone Health aim to improve breast cancer diagnostics with a new AI model.
Latest version of Galen™ transforms diagnosis of prostate, breast and gastric cancer and includes expanded detection, user-interface, and workflow integration capabilities.